Bioidentical Hormones Market – Promises a Striking Fortune of US$ 400 Million by 2023

“Market Research Future (MRFR)”
In the coming years, it is expected that the Global Bioidentical Hormones Market will advance with higher growth rate as compared to previous years. Rising pressure to curb healthcare costs has fuelled the growth of the market for Bioidentical Hormones Market. adds “Bioidentical Hormones Market -2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023” reports to its database.

The report titled “Bioidentical Hormones Market -Forecast to 2023″ is a direct appreciation by Market Research Future of the market potential of the Bioidentical Hormones Market. The report intends to provide accurate and meaningful insights, both quantitative as well as qualitative. It can be said with high confidence level, that this report will satisfy the need for comprehensive insights needed to compete and beat other players in today’s winner takes all market! The global bioidentical hormones market is expected to reach US$ 400 million by 2023, and the market is projected to grow at a CAGR of ~ 5.2 % during the forecast period 2017-2023.

Global Bio Identical Hormones Market – Regional Analysis:

The market of bio identical hormones is much higher in the Americas region. There are huge population which are suffering from disease such as heart disease, stroke, Alzheimer’s disease, endometrial and breast cancer. According to the report published by Centers for Disease Control and Prevention (CDC), in 2017, around 630,000 Americans died from heart disease every year that is 12 in every 4 death. There are huge population suffering with chronic disease, thus market players have good opportunity to maximize their profit with in this region owing to high awareness of healthcare awareness. According to Centers for Disease Control and Prevention (CDC), in 2015, around 366,000 people were died from Coronary heart disease and it is the most common type of heart disease. Report suggest that Heart disease is the leading cause of death for both men and women. More than half of the men deaths in United States were due to heart disease in 2015. These statistic shows the huge opportunity for the players.

Europe is also considered a huge market for bio identical hormones players, owing to present of huge population affected with chronic disease. Government are more focusing on research and development to introduce new therapy and best treatment for their citizen.

Asia Pacific and the Middle East and Africa region are considering the big market. Whereas country like India and china of Asia Pacific region are considering fastest growing region due to presence of huge population suffering with chronic disease, additionally they are open to adopt new technology, and best treatment option from developed countries in order to improve the quality of life for their public. Whereas the Middle East and Africa are low market due to his incapability of investment. Developing countries are focusing on new drugs and therapy for the treatment of chronic disease, this gap between the developed and developing countries will present significant growth opportunity for the bio identical hormones market players in the coming years.

Global Bio Identical Hormones Market – Major Players:

SottoPelle, BioTE Medical (U.S.), Advantage Pharmaceuticals, Inc. (U.S.), Full Life Wellness Center (U.S.), Neuva Aesthetics (U.S.), and Defy Medical (U.S.) are some of the leading players at the cutting edge of the competition in the market of bio identical hormones, globally.

Bio identical hormones are biochemically the same as those made by our body naturally, unlike conventional hormone therapy that uses synthetic hormones or animal-based hormones. These hormones are very same as hormones produce by human body and are used for treatment of hormones deficiency. According to the Food and Drug Administration (FDA) and several medical specialty groups, Bio identical hormones are not much safer than hormones used in traditional therapy, and also there is no evidence that bio identical are more effective in comparison to traditional bio identical therapy.

Global Bio Identical Hormones Market – Overview:

The global bio identical hormones market is rising with a moderate phase; mainly owing to increase in patient population. This therapy have ability to treat conditions such as heart disease, stroke, Alzheimer’s disease, endometrial, and breast cancer. According to the WHO, in 2015, around 570,000 women died from breast cancer globally, which are approximately 15% of all cancer deaths among women. Breast cancer is most frequent cancer among the women, and impacting around 1.5 million women every year. Increasing consumer awareness about technology associated with bio identical hormones therapy and increasing population globally leads the bio identical hormones market.

Companies are continuously inventing new products to capture the market globally. Thus, major players are investing more in research and development activity, in order to lead the global market. In this regards, BioTE Medical, in 2017, announces that about nine medical experts across the United States are gathering together in order to introduce best testosterone therapy for women. Most of the research commentary on BHRT focuses on the effects of testosterone therapy in men. Yet, the data is there to support the health advantages in women. In 2016, BioTE Medical is focusing on expanding the nationwide network of certified physicians into the Atlanta, Georgia market. This networking helped the company to reach the patient population and capture the market. These research and development will help company to lead the market. Increasing in obesity population globally and unhealthy diet are the factors that leads the market of bio identical hormones. Moreover companies are more focus to capture the market.


Global Bioidentical Hormones Market – Segmentation:
The global bioidentical hormones market has been segmented on the basis of types, product types, and end users.

Based on types, the market has been segmented as estrogens, progesterone, testosterone, others.

Based on product types, the market has been segmented as tablets and capsules, creams and gels, injectable, patches and implants, and others.

Based on the end users, the market has been segmented as hospitals & gynecology clinics, academic and research and others.

Major TOC of Global Bioidentical Hormones Market:

Chapter 1. Introduction

Chapter 2. Research Methodology

Chapter 3. Market Dynamics

Chapter 4. Market Factor Analysis

Chapter 5. Global Bioidentical Hormones Market, By Types

Chapter 6. Global Bioidentical Hormones Market, By Product Types

Chapter 7. Global Bioidentical Hormones Market, By End Users

Chapter 8. Global Bioidentical Hormones Market, By Region

Chapter 9. Competitive Landscape

Chapter 10. Company Profile

Chapter 11. Conclusion

Chapter 12. Appendix



About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.


Media Contact
Company Name: Market Research Future
Contact Person: Akash Anand
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune –
City: Pune
State: Maharashtra
Country: India